Chicago Atlantic BDC Forms $613M BDC After Merger

Chicago Atlantic Real Estate Finance (REFI) and Chicago Atlantic BDC (LIEN) announced a definitive all-stock merger agreement on June 18, 2026, creating a combined business development company with a pro-forma net asset value of $613 million and a $771 million investment portfolio. REFI will elect to be regulated as a BDC and merge into LIEN, with the surviving entity trading on Nasdaq under the ticker "LIEN."

The deal is structured as a NAV-for-NAV exchange, with REFI stockholders receiving LIEN shares based on each company's adjusted net asset value per share as of the transaction date. Based on respective NAVs as of March 31, 2026, former REFI stockholders would own approximately 50.5% of the combined entity at closing, making it roughly an equal merger by economic weight. Peter Sack will lead the combined company as Chief Executive Officer. The transaction is targeted to close in the fourth quarter of 2026, subject to shareholder and regulatory approvals.

Chicago Atlantic's two platforms bring complementary lending books to the combination. REFI has focused primarily on real estate-backed loans, while LIEN has pursued direct lending and cash-flow loans, many of them in the cannabis and specialty finance sectors. The combined BDC is expected to carry a 16.7% trailing twelve-month realized gross yield, reflecting the higher-risk, higher-return profile of its borrower base. Management cited enhanced diversification across collateral types and expanded access to debt capital markets at larger scale as the primary strategic rationale.

The $613 million NAV figure is the key threshold here. BDC scale matters for index eligibility, secondary market liquidity, and unsecured debt access. Sub-scale BDCs often trade at persistent NAV discounts due to limited float and investor awareness; the merged entity could reduce that discount pressure by crossing into a more institutionally relevant size band. That said, integration of two distinct credit cultures and loan books carries execution risk during a period when specialty lending credit quality is receiving heightened scrutiny.